Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

1 H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism

1 H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on... Von Hippel‐Lindau (VHL) is an onco‐suppressor involved in oxygen and energy‐dependent promotion of protein ubiquitination and proteosomal degradation. Loss of function mutations of VHL (VHL‐cells) result in organ specific cancers with the best studied example in renal cell carcinomas. VHL has a well‐established role in deactivation of hypoxia‐inducible factor (HIF‐1) and in regulation of PI3K/AKT/mTOR activity. Cell culture metabolomics analysis was utilized to determined effect of VHL and HIF‐1α or HIF‐2α on metabolism of renal cell carcinomas (RCC). RCC cells were stably transfected with VHL or shRNA designed to silence HIF‐1α or HIF‐2α genes. Obtained metabolic data was analysed qualitatively, searching for overall effects on metabolism as well as quantitatively, using methods developed in our group in order to determine specific metabolic changes. Analysis of the effect of VHL and HIF silencing on cellular metabolic footprints and fingerprints provided information about the metabolic pathways affected by VHL through HIF function as well as independently of HIF. Through correlation network analysis as well as statistical analysis of significant metabolic changes we have determined effects of VHL and HIF on energy production, amino acid metabolism, choline metabolism as well as cell regulation and signaling. VHL was shown to influence cellular metabolism through its effect on HIF proteins as well as by affecting activity of other factors. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Cancer Wiley

1 H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism

Loading next page...
 
/lp/wiley/1-h-nmr-metabolomics-analysis-of-renal-cell-carcinoma-cells-effect-of-wx0AB03b0T

References (42)

Publisher
Wiley
Copyright
© 2016 UICC
ISSN
0020-7136
eISSN
1097-0215
DOI
10.1002/ijc.29947
pmid
26620126
Publisher site
See Article on Publisher Site

Abstract

Von Hippel‐Lindau (VHL) is an onco‐suppressor involved in oxygen and energy‐dependent promotion of protein ubiquitination and proteosomal degradation. Loss of function mutations of VHL (VHL‐cells) result in organ specific cancers with the best studied example in renal cell carcinomas. VHL has a well‐established role in deactivation of hypoxia‐inducible factor (HIF‐1) and in regulation of PI3K/AKT/mTOR activity. Cell culture metabolomics analysis was utilized to determined effect of VHL and HIF‐1α or HIF‐2α on metabolism of renal cell carcinomas (RCC). RCC cells were stably transfected with VHL or shRNA designed to silence HIF‐1α or HIF‐2α genes. Obtained metabolic data was analysed qualitatively, searching for overall effects on metabolism as well as quantitatively, using methods developed in our group in order to determine specific metabolic changes. Analysis of the effect of VHL and HIF silencing on cellular metabolic footprints and fingerprints provided information about the metabolic pathways affected by VHL through HIF function as well as independently of HIF. Through correlation network analysis as well as statistical analysis of significant metabolic changes we have determined effects of VHL and HIF on energy production, amino acid metabolism, choline metabolism as well as cell regulation and signaling. VHL was shown to influence cellular metabolism through its effect on HIF proteins as well as by affecting activity of other factors.

Journal

International Journal of CancerWiley

Published: May 15, 2016

Keywords: ; ; ; ; ; ;

There are no references for this article.